Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Cephalalgia. 2011 Dec 15;32(2):159–170. doi: 10.1177/0333102411430854

Associations of socioeconomic status with migraine and non-migraine headache

Anke C Winter 1, Klaus Berger 2, Julie E Buring 1, Tobias Kurth 1,3,4
PMCID: PMC3266434  NIHMSID: NIHMS341435  PMID: 22174348

Abstract

Background

Migraine has been linked with several measures of socioeconomic status (SES). However, results are inconsistent and data on the association between SES and non-migraine headache, migraine subtypes and migraine frequency are sparse.

Methods

We conducted a cross-sectional study among 36,858 participants in the Women’s Health Study. As proxy for SES, we calculated an SES index using annual household income and education. Migraine, migraine aura, and non-migraine headache were self-reported with good validation rates. Multinomial logistic regression models were used to evaluate the association between SES index and the various headache forms.

Results

12,140 (32.9%) women reported any history of headache, 6,801 women (18.4%) reported any history of migraine and 5,339 (14.5%) reported non-migraine headache. Women with low SES had an increased risk for all headache forms. The multivariable-adjusted OR (95% CI) were 1.22 (1.10–1.36) for non-migraine headache, 1.40 (1.28–1.54) for any migraine, 1.44 (1.23–1.69) for migraine with aura, and 1.38 (1.21–1.58) for migraine without aura. Among active migraineurs, low SES was associated with an increased OR for ≥weekly attack frequency (1.77, 1.26–2.49).

Conclusions

In this large cohort of female health professionals, low SES was associated with an increased prevalence for all headache forms and an increased migraine attack frequency.

Keywords: Migraine, non-migraine headache, migraine frequency, socioeconomic status

Introduction

The impact of socioeconomic inequalities on various health statuses has been studied frequently (1), particularly to identify potential targets for prevention or to initiate prevention strategies. The underlying mechanisms by which socioeconomic status (SES) might be linked to diverse health outcomes are still unclear.

From a public health perspective, especially, a relationship between SES and diseases with a high prevalence is of interest. Primary headache disorders are highly prevalent and particularly migraine headaches are resulting in large personal and societal burden (2). Approximately 18% of females and 6% of males experience at least one migraine attack per year (3). The prevalence of active migraine changes over lifespan with a peak in both sexes at ages 25–55, the most productive years of adulthood (4). The economic consequences of migraine is mainly reduced productivity caused by absenteeism or reduced performance at work (2).

The potential association between SES and migraine has been frequently studied with inconsistent results (511) and only two cross-sectional studies have evaluated migraine subtypes (12, 13). In addition, studies suggest an association between low SES and chronification of headache forms (1416). One potential mediator for this association is an increased migraine attack frequency, but only few studies have especially addressed the relation between SES and migraine attack frequency (6, 17, 18), also with inconsistent results.

The most commonly used indicators for SES are income, education and occupation (3, 5, 6, 810, 17, 1921). However, socioeconomic status is a multidimensional concept, which may not be well represented by single indicator variables. Combining SES proxies into an index has been proposed as an alternate method to measure SES and addresses the issue of multidimensionality (2225).

We therefore aim to evaluate the association of SES, represented by an SES index, with prevalence of migraine and non-migraine headache as well as with migraine attack frequency in a cohort over 39,000 female health professionals.

Methods

Study population

Study subjects were all participants in the Women’s Health Study (WHS), a completed randomized trial designed to test the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among apparently healthy women. The design, methods, and results have been described in detail previously (26, 27). In brief, a total of 39,876 U.S. female health professionals aged ≥45 years at baseline (1993–1995) and without a history of cardiovascular disease, cancer, or other major illnesses were randomly assigned to active aspirin (100mg on alternate days), active vitamin E (600 IU on alternate days), both active agents, or both placebos. All participants provided written informed consent and the Institutional Review Board of the Brigham and Women’s Hospital, Boston, Massachusetts approved the procedures of the WHS. Baseline information was self-reported and collected by a mailed questionnaire that asked about many cardiovascular risk factors and lifestyle variables. Twice in the first year and yearly thereafter, participants were sent follow-up questionnaires asking about study outcomes and other information during the study period. Since the trial’s termination in 2004, observational follow-up is still ongoing.

Assessment of migraine

On the baseline questionnaire, participants were asked: “Have you ever had migraine headaches?” and “In the past year, have you had migraine headaches?” We distinguished between women without migraine history, who reported any migraine history, who reported active migraine (migraine in the year prior completing the baseline questionnaire), and who reported prior migraine, which includes women who reported ever having had a migraine but none in the year prior to completing the questionnaire. Our any migraine category included women with active migraine (migraine with aura, migraine without aura) and prior migraine. Those participants who reported active migraine were further asked details about their migraine attacks, including attack duration of 4 to 72 hours; unilateral location and pulsating quality of pain; inhibition of daily activities; aggravation by routine physical activity; nausea or vomiting; and sensitivity to light or sound. Furthermore, participants who reported active migraine were asked whether they had an “aura or any indication a migraine is coming”. Responses were used to classify women who reported active migraine into migraine with aura and migraine without aura, similar to previous studies (28, 29). In addition, active migraineurs were asked details about the frequency of their migraine attacks (daily, weekly, monthly, every other month, < 6 times/year).

In previous studies of the WHS, we have shown good agreement between migraine classification based on International Headache Society criteria. Specifically, we have shown in a substudy of the WHS that over 87% of women with active migraine could be diagnosed as migraine without aura (71.5%) or probable migraine without aura (16.2%) when applying current revised criteria (30).

Ascertainment of non-migraine headache

Participants were asked to report on the 6-month follow-up questionnaire whether they have ever had headaches. We subsequently categorized women in having non-migraine headache, if a women reported headache but did not indicate any history of migraine similar to a previous study (29). Women who reported both migraine and non-migraine headache were classified as migraineurs.

Assessment of socioeconomic status

At enrollment, participants were asked to report the total annual household income in the year prior the baseline questionnaire and their highest level of education. We defined 6 categories of income (≤$19,999, $20,000–29,999, $30,000–39,999, $40,000–49,999, $50,000–99,999, and ≥$ 100,000), and 6 levels of education (< 2 years of nursing education, 2 years of nursing education, 3 years of nursing education, a bachelor’s degree, a master’s degree, and a doctoral degree). Based upon this information, we created a SES index (Table 1).

Table 1.

Distribution of SES variables according to SES Index categories* in the Women’s Health Study (N=36,858)

SES Index
SES variable Points 0–3
n=12,805
34.7%
4
n=6,870
18.6%
5
n=5,281
14.3%
6–7
n=7,380
20.0%
8–10
n=4,522
12.3%
Total
N=36,858
p-value
Income, % <.0001
   ≤ 19,999 5 0.0 0.0 0.3 4.0 39.3 5.7
   20,000–29,999 4 0.0 0.6 4.0 24.2 38.6 10.3
   30,000–39,999 3 0.7 7.6 19.7 35.5 22.1 14.3
   40,000–49,999 2 7.3 21.1 38.7 22.5 0.0 16.5
   50,000–99,999 1 59.0 66.3 35.9 13.8 0.0 40.8
   ≥ 100,000 0 33.0 4.6 1.4 0.0 0.0 12.5
   Contribution to index - 0.34 0.33 0.38 0.44 0.48 -
Education, % <.0001
   < 2 years of nursing education 5 0.0 0.0 1.4 25.0 72.8 14.1
   2 years of nursing education 4 0.0 4.6 35.9 20.5 12.1 11.6
   3 years of nursing education 3 7.8 66.3 38.7 44.1 15.1 31.3
   Bachelor’s degree 2 41.8 21.1 19.7 9.2 0.0 23.1
   Master’s degree 1 36.8 7.6 4.0 1.1 0.0 15.0
   Doctorate/MD 0 13.6 0.6 0.3 0.0 0.0 4.9
   Contribution to index - 0.66 0.67 0.62 0.56 0.52 -
*

Percentages may not add up to 100 because of rounding.

Assigned point value to create SES index.

Mean SES index score from income in SES index category divided by mean SES index score in the category.

Mean SES index score from education in SES index category divided by mean SES index score in the category.

Point values of 0 to 5 were assigned to each individual variable category as follows: the highest point value (5) was assigned to the lowest income and education categories, respectively. The assigned point values decreased with increasing income and education levels. The highest income and education categories received the lowest point value (0). We then combined the income and education variable to an overall SES index which ranged from 0–10. We divided the overall SES index into quintiles. The lowest quintile represented the highest level of SES and was used as reference category in further analysis. The assigned point scheme and the distribution of the SES variables according to the SES index categories are presented in Table 1.

Studies analyzing data from the general population often additionally include a proxy for occupation in their SES index (23, 24). Since our cohort consists of health professionals, our education and professional occupation variables are very closely related. We decided not to include occupation in our index because of a rather small variation in this traditional SES indicator.

Statistical methods

Of the 39, 876 women, a total of 3,018 women were excluded (missing data on migraine status (n=119), education (n=669) or income (n=2,230)), leaving 36, 858 participants for this analysis. Because age differed according to SES index, we used direct standardization to adjust categorical variables for age in 5 year increments to compare baseline characteristics according to SES index categories.

Multinominal logistic regression models were calculated to evaluate the association between SES index categories and headache subtypes with SES index as the independent and headache subtypes as the dependent variable. We run two multinominal models, one including information on any migraine, non-migraine headache, and no history of headache (reference group) and the other one including migraine with aura, migraine without aura, prior migraine, non-migraine headache, and no history of headache (reference group). Multinomial logistic regression is an extension of binary logistic regression that allows the dependent variable to have more than two categories and then simultaneously compares each of these categories to a reference category. Women within the lowest SES quintile and no history of any headache were used as reference group. Prevalence odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for the association between SES index and the various headache forms.

We further evaluated the association between SES index and migraine attack frequency (daily and weekly, monthly, every other month, <6 times per year) using multinomial logistic regression models. Because of low case counts, we collapsed the SES index quintiles into a binary variable (SES index point values 8–10 versus SES index point values 0–7) for this part of the analysis. Women with a SES index between 0 and 7 with a migraine attack frequency of less than 6 times per year serve as reference category.

We run age- and multivariable-adjusted models. We selected covariates as potential confounder if they were related with migraine and SES status. The multivariable models were adjusted for age (continuous), race (white, non-white), marital status (single, married, divorced, widowed), geographic region (Northeast, Southeast, Midwest, West), history of hypertension, postmenopausal hormone use (never, past, current), and postmenopausal status (premenopausal, postmenopausal, biologically uncertain, unclear). To determine whether the associations are influenced by life style factors, we additionally adjusted the multivariable models for smoking status (never, current, past), body mass index (<25 kg/m2, 25.0–<30.0 kg/m2, ≥30 kg/m2), exercise (never, <1/week, 1–3 times/week, ≥4 times/week) and alcohol consumption (never, 1–3 drinks/month, 1–6 drinks/week, ≥1 drink/day).

To assess the impact of each single SES indicator separately, we additionally calculated multinominal logistic regression models with income and education as exposure variable.

A missing value indicator was included for all covariates if the number of women with missing information was ≥100. We assigned participants with missing values to the reference category of the covariate if the number of missing information was less than 100. The total number of missing values for all covariates was 2,375 (6.4%).

For all analysis, we used SAS (version 9.1; SAS Institute Inc., Cary, NC, USA). All p-values were two-tailed and p < 0.05 was considered statistically significant.

Results

Of the 36,858 women, a total of 12,140 (32.9%) women reported any history of headache, of whom 6,801 (18.4%) women reported any history of migraine and 5,339 (14.5%) reported non-migraine headache. Among the 4,791 (13.0%) active migraineurs (migraine in the year previous to baseline), 1,906 (39.8%) women indicated migraine with aura.

In Table 2, participants’ age-adjusted baseline characteristics according to SES index categories are presented. Women with low SES status (SES index 8–10) had a mean age of 57.6 years and were older compared to women with high SES status (SES index 0–3). They were more likely to have a history of migraine and non- migraine headache. Compared to women with higher SES statuses, women with low SES status were more likely to have BMI values ≥ 30kg/m2, to currently smoke, to rarely/never consume alcohol and to rarely/never exercise.

Table 2.

Age-adjusted baseline characteristics according to SES index categories* in the Women’s Health Study (N=36,858)

SES Index
0–3
n=12,805
34.7%
4
n=6,870
18.6%
5
n=5,281
14.3%
6–7
n=7,380
20.0%
8–10
n=4,522
12.3%
p-value
Demographic information
Mean age in years (SD) 52.9 (5.8) 53.8 (6.3) 54.4 (6.8) 56.5 (7.9) 57.6 (8.3) <.0001
Ethnicity, % <.0001
   White 93.8 96.2 96.0 95.7 91.9
   Hispanic 1.0 0.9 0.8 1.3 2.2
   African American 2.1 1.5 2.2 2.0 5.0
   Other 3.1 1.4 1.0 1.1 0.9
Geographic location, % <.0001
   Northeast 20.8 20.7 18.0 18.1 16.4
   Southeast 22.3 23.1 24.3 23.3 24.9
   Midwest 32.3 35.8 34.6 38.9 41.6
   West 24.6 20.4 23.1 19.7 17.1
Marital Status, % <.0001
   Single 6.8 5.6 5.5 5.1 6.6
   Married 80.1 79.2 72.7 67.0 53.1
   Divorced 9.5 10.9 15.7 19.5 28.0
   Widowed 3.6 4.4 6.2 8.4 12.3
   West 24.6 20.4 23.1 19.7 17.1
Headache history, % <.0001
   Migraine with aura 5.2 4.3 5.4 5.4 6.4
   Migraine without aura 7.3 7.9 7.7 8.3 8.9
   Prior migraine 5.1 5.2 5.0 5.6 7.1
   Non-migraine headache 14.3 13.7 14.6 14.2 16.0
   No history of headache 68.1 68.9 67.4 66.5 61.6
Life style variables, %
Body mass index (kg/m2) <.0001
   <25 57.4 51.0 49.1 45.8 38.3
   25–29.9 28.6 31.0 32.2 32.2 33.5
   ≥30 13.9 18.0 18.7 22.0 28.3
Smoking status <.0001
Never 54.2 48.9 51.2 49.2 46.2
Past 38.0 39.6 34.5 32.7 28.5
Current 7.8 11.5 14.3 18.1 25.2
Alcohol consumption <.0001
   Rarely/never 33.9 41.2 47.9 54.5 65.2
   1–3 drinks/month 13.7 13.7 13.3 13.0 10.8
   1–6 drinks/week 38.4 33.9 30.3 25.5 18.4
   ≥1 drink/day 14.0 11.2 8.6 7.0 5.5
Exercise
   Rarely/never 31.6 38.2 38.8 43.7 49.2 <.0001
   <1/week 19.2 19.8 21.2 20.6 19.3
   1–3 times/week 35.4 31.3 30.9 27.4 25.2
   ≥4 times/week 13.7 10.8 9.1 8.3 6.2
Other covariates, %
History of hypertension 21.9 25.1 26.1 27.7 35.2 <.0001
Menopausal status <.0001
   Premenopausal 30.1 28.7 26.5 25.5 21.8
   Postmenopausal 54.0 54.3 55.0 54.6 54.6
   Biological uncertain 11.7 13.2 14.8 16.2 19.4
   Unclear/subject unsure 4.1 3.9 3.8 3.6 4.1
Postmenopausal hormone use <.0001
   Never 47.4 48.1 46.5 47.5 48.3
   Past 7.7 9.4 9.7 12.8 15.3
   Current 44.9 42.5 43.8 39.7 36.4
*

Percentages may not add up to 100 because of rounding or missing values

Other include Asian pacific and American Indian

Table 3 summarizes the associations between the SES index and headache types. Women with the lowest SES status had a multivariable-adjusted OR for any migraine (OR:1.40, 95% CI: 1.28–1.54), active migraine with aura (OR: 1.44, 95% CI: 1.23–1.69), active migraine without aura (OR: 1.38, 95% CI: 1.21–1.58), prior migraine (OR: 1.36, 95% CI: 1.17–1.58) and non-migraine headache (OR: 1.22, 95% CI: 1.10–1.36), compared to women with the highest SES status who did not have a headache history (Model 1). These associations did not substantially chance after additional adjustment for life style factors (Model 2) and were mainly driven by income (Appendix Table 1).

Table 3.

Association between SES index and headache types (N=36,858)

SES index categories and
points
No of subjects with the
specific headache type
Age-adjusted OR
(95% CI)
Model 1
(95%CI)
Model 2
(95%CI)
Any migraine
     0–3 (n=12,805) 2,334 1.00 1.00 1.00
     4 (n=6,870) 1,211 0.98 (0.90, 1.06) 0.97 (0.90, 1.05) 0.96 (0.89, 1.04)
     5 (n=5,281) 955 1.04 (0.95, 1.13) 1.03 (0.95, 1.12) 1.00 (0.92, 1.09)
     6–7 (n=7,380) 1,359 1.12 (1.04, .1.21) 1.12 (1.04, 1.22) 1.09 (1.01, 1.18)
     8–10 (n=4,522) 942 1.41 (1.29, 1.54) 1.40 (1.28, 1.54) 1.36 (1.23, 1.49)
   Migraine with aura
     0–3 (n=12,805) 685 1.00 1.00 1.00
     4 (n=6,870) 308 0.86 (0.75, 0.98) 0.86 (0.75, 0.99) 0.85 (0.74, 0.98)
     5 (n=5,281) 286 1.08 (0.93, 1.24) 1.08 (0.94, 1.25) 1.05 (0.90, 1.21)
     6–7 (n=7,380) 369 1.08 (0.95, 1.24) 1.11 (0.97, 1.27) 1.06 (0.93, 1.22)
     8–10 (n=4,522) 258 1.39 (1.19, 1.61) 1.44 (1.23, 1.69) 1.38 (1.17, 1.62)
   Migraine without aura
     0–3 (n=12,805) 1,000 1.00 1.00 1.00
     4 (n=6,870) 561 1.08 (0.96, 1.20) 1.08 (0.96, 1.20) 1.06 (0.95, 1.18)
     5 (n=5,281) 408 1.06 (0.94, 1.20) 1.07 (0.94, 1.21) 1.03 (0.91, 1.17)
     6–7 (n=7,380) 561 1.15 (1.03, 1.29) 1.17 (1.05, 1.31) 1.13 (1.00, 1.26)
     8–10 (n=4,522) 355 1.34 (1.18, 1.53) 1.38 (1.21, 1.58) 1.33 (1.16, 1.62)
   Prior migraine
     0–3 (n=12,805) 649 1.00 1.00 1.00
     4 (n=6,870) 342 0.96 (0.84, 1.10) 0.93 (0.81, 1.07) 0.93 (0.81, 1.07)
     5 (n=5,281) 261 0.96 (0.83, 1.12) 0.93 (0.80, 1.08) 0.91 (0.79, 1.07)
     6–7 (n=7,380) 429 1.12 (0.98, 1.27) 1.07 (0.93, 1.22) 1.05 (0.92, 1.20)
     8–10 (n=4,522) 329 1.47 (1.28, 1.70) 1.36 (1.17, 1.58) 1.34 (1.15, 1.56)
Non-migraine headache
     0–3 (n=12,805) 1,912 1.00 1.00 1.00
     4 (n=6,870) 963 0.95 (0.87, 1.03) 0.95 (0.87, 1.03) 0.93 (0.85, 1.01)
     5 (n=5,281) 774 1.03 (0.94, 1.13) 1.02 (0.93, 1.12) 0.99 (0.90, 1.08)
     6–7 (n=7,380) 1,009 1.02 (0.93, 1.11) 1.01 (0.93, 1.11) 0.97 (0.89, 1.07)
     8–10 (n=4,522) 681 1.24 (1.12, 1.36) 1.22 (1.10, 1.36) 1.16 (1.04, 1.29)

Results from multinominal logistic regression models with the headache categories as dependent and SES index categories as independent variables. One model had the headache categories any migraine, non-migraine headache, and no headache as outcomes and another model had the migraine subgroups instead of any migraine as outcome. Women without headache and who have a SES index of 0.3 served as reference group.

Model 1: adjusted for age, race, marital status, geographic region, menopausal status, hormone use, history of hypertension

Model 2: Model 1 plus alcohol, smoking, BMI, exercise

In Table 4, the associations between SES index and migraine attack frequency are summarized. Compared with women with higher SES status (SES index 0–7) and a migraine attack frequency of less than 6 times per year, women with low SES status (SES index 8–10) had a multivariable-adjusted OR of 1.77 (1.26, 2.49) for having at least one migraine attack per week. This association between SES index and the various headache forms was not attenuated by life style factors (Model 2). In the analysis evaluating single SES proxies, income and not education was associated with an increased attack frequency (data not shown).

Table 4.

Association between SES index and migraine frequency (n=4,731)

SES Index categories and points No of subjects Age-adjusted OR Model 1 Model 2
Daily and weekly migraine attack frequency
   0–7 (n=4,125) 195 1.00 1.00 1.00
   8–10 (n=606) 51 1.74 (1.25, 2.43) 1.77 (1.26, 2.49) 1.65 (1.16, 2.35)
Monthly migraine attack frequency
   0–7 (n=4,125) 833 1.00 1.00 1.00
   8–10 (n=606) 102 0.88 (0.70, 1.11) 0.94 (0.74, 1.20) 0.96 (0.75, 1.22)
Every other months
   0–7 (n=4,125) 420 1.00 1.00 1.00
   8–10 (n=606) 50 0.82 (0.60, 1.13) 0.88 (0.64, 1.22) 0.95 (0.69, 1.32)
< 6 times/year
   0–7 (n=4,125) 2,677 1.00 1.00 1.00
   8–10 (n=606) 403 1.00 1.00 1.00

Model 1: adjusted for age, race, marital status, geographic region, menopausal status, hormone use, history of hypertension

Model 2: Model 1 plus alcohol, smoking, BMI, exercise

Discussion

In this large cross-sectional study of women with a profession in the health sector, low SES status was associated with an increased OR for any evaluated headache form, including migraine with aura, migraine without aura and non-migraine headache. Furthermore, active migraineurs with low SES had an increased OR for ≥ weekly migraine attack frequency. Additional adjustment for life style factors did not substantially change the effect estimate suggesting that the observed associations is unlikely explained by lifestyle habits in our cohort. When comparing the two SES proxies, income and education, income predominately contributed to the observed relationship between SES status, headache prevalence and migraine attack frequency.

The relationship between SES and migraine prevalence has been studied frequently. Several studies support our finding of an association between low SES and overall migraine prevalence (3, 8, 12, 19, 31). The majority of studies assessed the association between SES and migraine in general. In a cross-sectional study of 12,750 participants from the United States distinguishing between migraine subtypes, low income was associated with an increased OR for migraine with aura (OR: 1.68, 95% CI: 1.07–2.64), migraine without aura (OR: 1.56, 95% CI: 1.14–2.14) and other headaches with aura (OR:1.89, 95% CI: 1.14–3.13) (12). In a Danish cohort of 31,865 participants, low educational levels were associated with an increased multivariable-adjusted OR of 1.30 (1.08–1.56) for migraine without aura in women (13). In contrast, studies from Canada (9) Netherlands (17) and Sweden (5) found no association between SES assessed by income or education and migraine prevalence.

We have additionally evaluated data on non-migraine headache. Our non-migraine headache category includes participants with headache other than migraine but the cases are not further classified according to diagnostic criteria. However, as along with migraine, tension-type headache is the most common primary headache disorder and other headache forms are very rare in the general population, we believe that our non-migraine headache group is driven by tension-type headache. Several studies report an association between either low or high educational levels and tension-type headache (3234). Other studies could not confirm these results and found no association between SES and TTH or other non-migraine headache forms (18, 20, 32, 35, 36).

Only few studies have evaluated the relationship between SES and migraine attack frequency (6, 17, 18). Two studies are in line with our finding and report an association between low SES and frequent headache with migrainous features (18) and frequent headache (migraine and non-migrainous headache) (6) while a study from the Netherlands found no significant differences in attack frequency by SES (17). Data on headache frequency in the non-migraine headache group was not available in our study.

SES is a complex, multidimensional concept and hard to measure. Most studies evaluating the association between SES and headache have used either income or education as a single proxy for SES. The application of a SES index instead of one single measure has several advantages. Firstly, the SES index addresses SES as a multidimensional concept. Secondly, using a SES index reduces the dominance of one single SES measure and allows variation across categories. Indeed, the average contribution of income and education varies according to our SES index categories (Table 1). In the high SES index category, both income and education contribute about half to the combined SES index score while in the low SES index category education contributes about two thirds. Single measures, e.g. education or income, represent different dimensions when used as indicators for SES. Education reflects a person’s individual intellectual abilities and may also be associated with different health behaviors. Compared to other SES proxies, education is stable measure, but may rather represent earlier life circumstances. Annual household income is an economic indicator and several family members may unequally contribute and have access to it. Although income is a more recent indicator for SES, it is prone to fluctuations and may be a result of prevalent health problems (37).

The mechanisms by which SES might be related to migraine prevalence and migraine frequency are unclear. Stress linked to economic hardship and working conditions, diverse diet patterns and different access to medical care may influence this association. Furthermore, the direction of the association still has to be determined. Bigal and colleagues have evaluated two opposing hypothesis, social causation and social selection, for the association between SES and migraine (38). The social causation hypothesis suggests that factors associated with low SES increase disease prevalence. In contrast, according to the social selection theory, the disease itself affects the individual’s educational and occupational abilities and subsequently leads to lower SES (39). Results of the study suggest that social causation rather than social selection might contribute to the relationship between SES and migraine prevalence (38). However, most of the studies assessing SES and migraine, including our study, have a cross-sectional design not allowing addressing the directionality and causative pathways of the association.

Our study has several strengths including the large number of participants and the large number of individuals with various headache forms. Our migraine assessment has been shown to be valid (30) and we could distinguished migraine subtypes as well as migraine attack frequency. The WHS provides information about a large number of potential confounders allowing us to adjust the association between SES and migraine.

The following limitations should be considered when interpreting our results. Firstly, information on migraine, migraine features and migraine frequency is self-reported and underreporting or misclassification is possible. Secondly, information on the SES variables and the potential confounders is also self-reported. However, as information on education and income are related to headache-specific information, such misclassification is expected to be random. Lastly, our cohort consists of female health professional aged ≥ 45 years which may limit the generalizability of our results to other populations.

In conclusion, data from this large cohort of female health professionals indicate an association between low SES status and any headache form. In addition, we found an association between low SES status and migraine attack frequency. These results support further targeted research on potential triggering factors of headache in lower SES groups and exploration of potential preventive strategies.

Acknowledgements

We are indebted to the participants in the Women’s Health Study for their outstanding commitment and cooperation, to the entire Women’s Health Study staff for their expert and unfailing assistance.

Funding:

This study was supported in part by an international postdoctoral research fellowship of the American Association of University Women to Dr. Winter. The Women’s Health Study is supported by grants from the National Heart, Lung, and Blood Institute (HL-043851 and HL-080467); and the National Cancer Institute (CA-47988). The sponsors of the study played no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Disclosure:

We report a full disclosure for the last 2 years for each author:

Dr. Winter has received an international postdoctoral research fellowship of the American Association of University Women for conducting this study and is currently funded by a research fellowship of the German Research Foundation.

Dr. Berger has received research support for the conduction of DMKG Headache Study unrestricted grants of equal share from the German Migraine and Headache Society and a consortium formed by Allmiral, Astra-Zeneca, Berlin-Chemie, Boehringer Ingelheim Pharma, Boots Healthcare, GlaxoSmithKline, Janssen Cilag, McNeil Pharmaceuticals, MSD Sharp & Dohme, Pfizer; -for the 'Course of Restless Legs Syndrome Study' unrestricted grants from the German Restless Legs Society and a consortium formed by Boehringer Ingelheim Pharma, Mundipharma Research, Neurobiotec, UCB (Schwarz Pharma) and Roche Pharma; from the German Minister of Research and Education for several research projects within the German Competence Net Stroke and an ongoing cohort study on depression and subclinical arteriosclerosis.

Dr. Buring has received investigator-initiated research funding and support from the National Institutes of Health and Dow Corning Corporation; research support for pills and/or packaging from Bayer Health Care and the Natural Source Vitamin E Association.

Dr. Kurth has received investigator-initiated research funding from the French National Research Agency, the US National Institutes of Health, Merck, the Migraine Research Foundation, and the Parkinson’s disease Foundation. He is a consultant to World Health Information Science Consultants, LLC, and has received honoraria from the American Academy of Neurology and Merck for educational lectures and from MAP Pharmaceutical for contributing to a scientific advisory panel.

Appendix table 1

Association between annual household income levels and headache subtypes (N=36,858)

Income categories (USD) No of subjects with the
specific headache type
Age-adjusted OR
(95% CI)
Model 1
(95%CI)
Model 2
(95%CI)
Any migraine (n=6,801)
     ≤ 19,999 376 1.28 (1.11, 1.47) 1.35 (1.17, 1.57) 1.24 (1.07, 1.45)
     20,000–29,999 668 1.10 (0.98, 1.23) 1.13 (1.00, 1.27) 1.05 (0.92, 1.18)
     30,000–39,999 946 1.04 (0.94, 1.16) 1.07 (0.96, 1.19) 1.00 (0.89, 1.12)
     40,000–49,999 1,113 1.00 (0.91, 1.11) 1.01 (0.91, 1.12) 0.95 (0.86, 1.06)
     50,000–99,999 2,795 0.99 (0.91, 1.07) 0.98 (0.90, 1.07) 0.94 (0.86, 1.03)
     ≥ 100,000 903 1.00 1.00 1.00
   Migraine with aura (n=1,906)
     ≤ 19,999 86 1.04 (0.80, 1.34) 1.19 (0.91, 1.55) 1.06 (0.81, 1.40)
     20,000–29,999 191 1.07 (0.88, 1.30) 1.17 (0.95, 1.43) 1.06 (0.86, 1.30)
     30,000–39,999 252 0.92 (0.77, 1.10) 0.99 (0.83, 1.19) 0.91 (0.75, 1.10)
     40,000–49,999 322 0.94 (0.80, 1.11) 0.99 (0.83, 1.17) 0.91 (0.77, 1.09)
     50,000–99,999 770 0.87 (0.75, 1.00) 0.88 (0.76, 1.01) 0.83 (0.72, 0.96)
     ≥ 100,000 285 1.00 1.00 1.00
   Migraine without aura (n=2,885)
     ≤ 19,999 119 1.14 (0.92, 1.43) 1.25 (1.00, 1.58) 1.13 (0.89, 1.43)
     20,000–29,999 264 1.15 (0.97, 1.36) 1.21 (1.02, 1.45) 1.10 (0.92, 1.32)
     30,000–39,999 394 1.11 (0.95, 1.29) 1.15 (0.99, 1.35) 1.06 (0.90, 1.24)
     40,000–49,999 458 1.02 (0.88, 1.17) 1.04 (0.90, 1.21) 0.96 (0.82, 1.11)
     50,000–99,999 1,270 1.07 (0.95, 1.21) 1.08 (0.96, 1.22) 1.02 (0.90, 1.15)
     ≥ 100,000 380 1.00 1.00 1.00
   Prior Migraine (n=2,010)
     ≤ 19,999 171 1.55 (1.25, 1.93) 1.47 (1.17, 1.85) 1.42 (1.12, 1.80)
     20,000–29,999 213 1.06 (0.87, 1.29) 1.00 (0.81, 1.22) 0.97 (0.79, 1.19)
     30,000–39,999 300 1.09 (0.91, 1.30) 1.03 (0.86, 1.24) 1.01 (0.84, 1.22)
     40,000–49,999 333 1.05 (0.88, 1.25) 1.01 (0.84, 1.20) 0.98 (0.82, 1.18)
     50,000–99,999 755 0.99 (0.85, 1.15) 0.96 (0.82, 1.11) 0.94 (0.81, 1.10)
     ≥ 100,000 238 1.00 1.00 1.00
Non-migraine headache (n=5,339)
     ≤ 19,999 306 1.55 (1.33, 1.82) 1.63 (1.38, 1.92) 1.51 (1.28, 1.79)
     20,000–29,999 516 1.26 (1.11, 1.44) 1.29 (1.13, 1.48) 1.21 (1.05, 1.39)
     30,000–39,999 749 1.23 (1.09, 1.39) 1.26 (1.11, 1.42) 1.18 (1.04, 1.34)
     40,000–49,999 860 1.15 (1.02, 1.29) 1.16 (1.03, 1.31) 1.09 (0.97, 1.23)
     50,000–99,999 2,299 1.20 (1.09, 1.33) 1.20 (1.09, 1.33) 1.15 (1.04, 1.27)
     ≥ 100,000 609 1.00 1.00 1.00

Results from multinominal logistic regression models with the headache categories as dependent and SES index categories as independent variables. One model had the headache categories any migraine, non-migraine headache, and no headache as outcomes and another model had the migraine subgroups instead of any migraine as outcome. Women without headache and who have an income of ≥ 100,000 served as reference group.

Model 1: adjusted for age, race, marital status, geographic region, menopausal status, hormone use, history of hypertension

Model 2: Model 1 plus alcohol, smoking, BMI, exercise

Appendix table 2

Association between highest education levels and headache subtypes (N=36,858)

Education categories No of subjects with the
specific headache type
Age-adjusted OR
(95% CI)
Model 1
(95%CI)
Model 2
(95%CI)
Any migraine (n=6,801)
     < 2 years of nursing education 1,160 1.16 (1.01, 1.33) 1.10 (0.96, 1.27) 1.06 (0.92, 1.22)
     2 years of nursing education 935 1.06 (0.92, 1.22) 1.00 (0.87, 1.16) 0.97 (0.84, 1.12)
     3 years of nursing education 1,879 0.79 (0.69, 0.90) 0.78 (0.68, 0.88) 0.76 (0.67, 0.87)
     Bachelor’s degree 1,531 0.84 (0.74, 0.96) 0.83 (0.73, 0.95) 0.81 (0.71, 0.93)
     Master’s degree 934 0.78 (0.68, 0.90) 0.78 (0.68, 0.89) 0.77 (0.67, 0.87)
     Doctorate/MD 362 1.00 1.00 1.00
   Migraine with aura (n=1,906)
     < 2 years of nursing education 339 1.02 (0.82, 1.27) 0.98 (0.79, 1.23) 0.93 (0.74, 1.17)
     2 years of nursing education 283 0.95 (0.76, 1.19) 0.90 (0.71, 1.13) 0.86 (0.68, 1.08)
     3 years of nursing education 465 0.60 (0.49, 0.74) 0.60 (0.48, 0.74) 0.58 (0.47, 0.72)
     Bachelor’s degree 431 0.71 (0.57, 0.87) 0.70 (0.56, 0.86) 0.68 (0.55, 0.84)
     Master’s degree 268 0.67 (0.53, 0.84) 0.67 (0.54, 0.84) 0.66 (0.53, 0.83)
     Doctorate/MD 120 1.00 1.00 1.00
   Migraine without aura (n=2,885)
     < 2 years of nursing education 468 1.24 (1.02, 1.53) 1.24 (1.01, 1.53) 1.20 (0.97, 1.48)
     2 years of nursing education 395 1.16 (0.94, 1.42) 1.14 (0.92, 1.41) 1.10 (0.89, 1.36)
     3 years of nursing education 805 0.93 (0.77, 1.13) 0.95 (0.78, 1.16) 0.93 (0.76, 1.13)
     Bachelor’s degree 683 0.99 (0.81, 1.20) 1.01 (0.83, 1.23) 0.98 (0.81, 1.20)
     Master’s degree 399 0.88 (0.71, 1.08) 0.89 (0.72, 1.09) 0.88 (0.71, 1.08)
     Doctorate/MD 135 1.00 1.00 1.00
   Prior Migraine (n=2,010)
     < 2 years of nursing education 353 1.21 (0.96, 1.51) 1.06 (0.84, 1.33) 1.04 (0.83, 1.32)
     2 years of nursing education 257 1.07 (0.85, 1.36) 0.95 (0.75, 1.21) 0.94 (0.74, 1.20)
     3 years of nursing education 609 0.82 (0.67, 1.02) 0.76 (0.61, 0.94) 0.75 (0.61, 0.94)
     Bachelor’s degree 417 0.82 (0.66, 1.02) 0.77 (0.61, 0.96) 0.76 (0.61, 0.95)
     Master’s degree 267 0.80 (0.63, 1.00) 0.76 (0.60, 0.97) 0.76 (0.60, 0.97)
     Doctorate/MD 107 1.00 1.00 1.00
Non-migraine headache (n=5,339)
     < 2 years of nursing education 799 1.14 (0.98, 1.34) 1.11 (0.95, 1.30) 1.04 (0.88, 1.22)
     2 years of nursing education 628 1.02 (0.87, 1.20) 0.98 (0.84, 1.16) 0.93 (0.79, 1.10)
     3 years of nursing education 1,550 0.94 (0.81, 1.08) 0.94 (0.81, 1.09) 0.90 (0.77, 1.04)
     Bachelor’s degree 1,283 1.01 (0.87, 1.18) 1.01 (0.87, 1.17) 0.97 (0.84, 1.13)
     Master’s degree 827 0.99 (0.85, 1.16) 1.00 (0.85, 1.17) 0.98 (0.83, 1.14)
     Doctorate/MD 252 1.00 1.00 1.00

variables. One model had the headache categories any migraine, non-migraine headache, and no headache as outcomes and another model had the migraine subgroups instead of any migraine as outcome. Women without headache and who have a doctorate/MD degree served as reference group.

Model 1: adjusted for age, race, marital status, geographic region, menopausal status, hormone use, history of hypertension

Model 2: Model 1 plus alcohol, smoking, BMI, exercise

References

  • 1.Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, Kunst AE. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358:2468–2481. doi: 10.1056/NEJMsa0707519. [DOI] [PubMed] [Google Scholar]
  • 2.Maki K, Vahtera J, Virtanen M, Elovainio M, Pentti J, Keltikangas-Jarvinen L, Kivimaki M. Sickness absence among female employees with migraine and co-existing conditions. Cephalalgia. 2008;28:1136–1144. doi: 10.1111/j.1468-2982.2008.01649.x. [DOI] [PubMed] [Google Scholar]
  • 3.Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–349. doi: 10.1212/01.wnl.0000252808.97649.21. [DOI] [PubMed] [Google Scholar]
  • 4.Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118 Suppl 1:3S–10S. doi: 10.1016/j.amjmed.2005.01.014. [DOI] [PubMed] [Google Scholar]
  • 5.Dahlof C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia. 2001;21:664–671. doi: 10.1046/j.1468-2982.2001.00218.x. [DOI] [PubMed] [Google Scholar]
  • 6.Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia. 2002;22:672–679. doi: 10.1046/j.1468-2982.2002.00413.x. [DOI] [PubMed] [Google Scholar]
  • 7.Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache. 1994;34:344–350. doi: 10.1111/j.1526-4610.1994.hed3406344.x. [DOI] [PubMed] [Google Scholar]
  • 8.Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–657. doi: 10.1046/j.1526-4610.2001.041007646.x. [DOI] [PubMed] [Google Scholar]
  • 9.O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994;23:1020–1026. doi: 10.1093/ije/23.5.1020. [DOI] [PubMed] [Google Scholar]
  • 10.Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, Zukerman E. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009;29:642–649. doi: 10.1111/j.1468-2982.2008.01782.x. [DOI] [PubMed] [Google Scholar]
  • 11.Stang PE, Yanagihara T, Swanson JW, Beard CM, Melton LJ., 3rd A population-based study of migraine headaches in Olmsted County, Minnesota. Case ascertainment and classification. Neuroepidemiology. 1991;10:297–307. doi: 10.1159/000110287. [DOI] [PubMed] [Google Scholar]
  • 12.Carson AP, Rose KM, Sanford CP, Ephross SA, Stang PE, Hunt KJ, et al. Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) study. Headache. 2004;44:20–28. doi: 10.1111/j.1526-4610.2004.04005.x. [DOI] [PubMed] [Google Scholar]
  • 13.Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J. Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. J Headache Pain. 2011;12:157–172. doi: 10.1007/s10194-011-0321-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–432. doi: 10.1136/jnnp.2009.192492. [DOI] [PubMed] [Google Scholar]
  • 15.Lipton RB. Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology. 2009;72:S3–S7. doi: 10.1212/WNL.0b013e3181974b19. [DOI] [PubMed] [Google Scholar]
  • 16.Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–89. doi: 10.1016/s0304-3959(03)00293-8. [DOI] [PubMed] [Google Scholar]
  • 17.Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537–542. doi: 10.1212/wnl.53.3.537. [DOI] [PubMed] [Google Scholar]
  • 18.Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497–506. doi: 10.1046/j.1526-4610.1998.3807497.x. [DOI] [PubMed] [Google Scholar]
  • 19.Fernandez-de-Las-Penas C, Hernandez-Barrera V, Carrasco-Garrido P, Alonso-Blanco C, Palacios-Cena D, Jimenez-Sanchez S, Jimenez-Garcia R. Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions. J Headache Pain. 2010;11:97–104. doi: 10.1007/s10194-009-0176-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol. 2005;161:1066–1073. doi: 10.1093/aje/kwi139. [DOI] [PubMed] [Google Scholar]
  • 21.Molarius A, Tegelberg A, Ohrvik J. Socio-economic factors, lifestyle, and headache disorders - a population-based study in Sweden. Headache. 2008;48:1426–1437. doi: 10.1111/j.1526-4610.2008.01178.x. [DOI] [PubMed] [Google Scholar]
  • 22.Clarke CA, Miller T, Chang ET, Yin D, Cockburn M, Gomez SL. Racial and social class gradients in life expectancy in contemporary California. Soc Sci Med. 2010;70:1373–1380. doi: 10.1016/j.socscimed.2010.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.James-Todd T, Tehranifar P, Rich-Edwards J, Titievsky L, Terry MB. The impact of socioeconomic status across early life on age at menarche among a racially diverse population of girls. Ann Epidemiol. 2010;20:836–842. doi: 10.1016/j.annepidem.2010.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.von Lengerke T, John J, Mielck A. Excess direct medical costs of severe obesity by socioeconomic status in German adults. Psychosoc Med. 2010;7 doi: 10.3205/psm000063. Doc01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yang J, Carmichael SL, Canfield M, Song J, Shaw GM. Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study. Am J Epidemiol. 2008;167:145–154. doi: 10.1093/aje/kwm283. [DOI] [PubMed] [Google Scholar]
  • 26.Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000;9:19–27. doi: 10.1089/152460900318911. [DOI] [PubMed] [Google Scholar]
  • 27.Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–1304. doi: 10.1056/NEJMoa050613. [DOI] [PubMed] [Google Scholar]
  • 28.Kurth T, Kase CS, Schurks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ. 2010;341:c3659. doi: 10.1136/bmj.c3659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005;64:1020–1026. doi: 10.1212/01.WNL.0000154528.21485.3A. [DOI] [PubMed] [Google Scholar]
  • 30.Schurks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia. 2009;29:1086–1090. doi: 10.1111/j.1468-2982.2008.01835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. Jama. 1992;267:64–69. [PubMed] [Google Scholar]
  • 32.Koseoglu E, Nacar M, Talaslioglu A, Cetinkaya F. Epidemiological and clinical characteristics of migraine and tension type headache in 1146 females in Kayseri, Turkey. Cephalalgia. 2003;23:381–388. doi: 10.1046/j.1468-2982.2003.00533.x. [DOI] [PubMed] [Google Scholar]
  • 33.Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, Zukerman E. A nationwide population-based study of tension-type headache in Brazil. Headache. 2009;49:71–78. doi: 10.1111/j.1526-4610.2008.01227.x. [DOI] [PubMed] [Google Scholar]
  • 34.Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. Jama. 1998;279:381–383. doi: 10.1001/jama.279.5.381. [DOI] [PubMed] [Google Scholar]
  • 35.Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, et al. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;73:1796–1803. doi: 10.1212/WNL.0b013e3181c34abb. [DOI] [PubMed] [Google Scholar]
  • 36.Rasmussen BK. Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol. 1992;21:1138–1143. doi: 10.1093/ije/21.6.1138. [DOI] [PubMed] [Google Scholar]
  • 37.Duncan GJ, Daly MC, McDonough P, Williams DR. Optimal indicators of socioeconomic status for health research. Am J Public Health. 2002;92:1151–1157. doi: 10.2105/ajph.92.7.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF. Migraine in adolescents: association with socioeconomic status and family history. Neurology. 2007;69:16–25. doi: 10.1212/01.wnl.0000265212.90735.64. [DOI] [PubMed] [Google Scholar]
  • 39.Hudson CG. Socioeconomic Status and Mental illness: Tests of the Social Causation and Selection Hypotheses. American Journal of Orthopsychiatry. 2005;75:3–18. doi: 10.1037/0002-9432.75.1.3. [DOI] [PubMed] [Google Scholar]

RESOURCES